Gary Phillips – CEO – Syntara (ASX:SNT) is a clinical-stage drug development company working to bring new and life-changing treatments to patients in need. The company has ongoing trials in myelofibrosis, myelodysplastic syndrome, scar prevention, modifcation of existing scars, isolated REM sleep behaviours disorder and Parkinson’s Disease.